Physician

Zakir Husain Shaik, MD

According to 2025 Medicare claims, Zakir Shaik, MD (NPI: 1700019874) practices nephrology in the Beaumont-Port Arthur, TX market, with the plurality of this provider's patient population coming from Jefferson, TX. This provider's primary affiliated billing organization is NECHES CLINIC PLLC (NPI: 1447629415; TIN: 474997152) and primary practice location at 77702-1100. Shaik is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Shaik's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 564 traditional Medicare patients, billed 3,350 HCPCS/CPT codes, and received $337,495 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 4,451 prescription claims across 664 beneficiaries totaling $724,471 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). DME data shows 70 claims. Open Payments data shows 3 records totaling $64. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $15,042 to $337,495. Similarly, Part D prescription costs have risen steadily, from $1,410 to $724,471. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $1,135 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	131	154	$15,042
2016	391	738	$65,739
2017	232	528	$55,325
2018	458	1,070	$95,981
2019	330	837	$72,820
2020	95	141	$12,954
2021	250	569	$60,807
2022	501	2,639	$309,354
2023	523	2,629	$346,141
2024	564	3,350	$337,495

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	11	39	$1,410
2016	41	94	$3,053
2017	68	194	$7,036
2018	180	450	$22,982
2019	136	291	$30,399
2020	13	40	$5,248
2021	100	213	$15,441
2022	341	1,519	$237,167
2023	499	2,976	$487,287
2024	664	4,451	$724,471

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	22	$896
2017	N/R	27	$953
2018	N/R	56	$1,169
2019	N/R	30	$1,146
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	48	$782
2024	N/R	70	$826

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	118	123	$126
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	268	575	$91
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	102	257	$88
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	180	747	$59
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	270	570	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	43	1,710	$135,886
Farxiga	Dapagliflozin Propanediol	136	5,871	$108,437
Xphozah	Tenapanor Hcl	32	1,020	$96,758
Jardiance	Empagliflozin	88	4,860	$91,964
Lokelma	Sodium Zirconium Cyclosilicate	51	2,095	$51,192

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	22	$238
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	12	$215
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	13	$197
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	12	$169
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	N	N/R	11	$7

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$64	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Zakir Husain Shaik, MD?

Tedicare shows public-source Medicare data for Zakir Husain Shaik, MD (NPI 1700019874), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Zakir Husain Shaik, MD have ACO affiliation data?

Zakir Husain Shaik, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Zakir Husain Shaik, MD?

Zakir Husain Shaik, MD is linked to NECHES CLINIC PLLC (billing NPI 1447629415) in the available physician profile data.

Does Zakir Husain Shaik, MD have Open Payments data?

Zakir Husain Shaik, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.